- Title: Subtitle
- 611 Biodistribution and shedding analysis following treatment with RP1 oncolytic immunotherapy in the skin cancer patients from the IGNYTE clinical trial
- Creators
- Mohammed MilhemAri VanderWalde - West Cancer CenterTawnya Bowles - Intermountain Medical CenterJoseph Sacco - Clatterbridge Cancer Centre NHS Foundation TrustAnna Olsson-BrownJiaxin NiuKaty Tsai - UCSF Helen Diller Family Comprehensive Cancer CenterJason Chesney - James Graham Brown FoundationBartosz Chmielowski - University of California, Los AngelesAdel Samson - University of LeedsTerence Rhodes - Intermountain Medical CenterGino In - USC Norris Comprehensive Cancer CenterAnna Pavlick - Cornell UniversityTrisha Wise-DraperMiguel SanmamedAlireza KalbasiColin LoveAaron ClackJeannie HouPraveen BommareddyRobert CoffinMark Middleton - Churchill HospitalKevin Harrington - Royal Marsden NHS Foundation Trust
- Resource Type
- Abstract
- Publication Details
- Regular and Young Investigator Award Abstracts, Vol.10(Suppl. 2), p.A643
- DOI
- 10.1136/jitc-2022-sitc2022.0611
- Publisher
- BMJ Publishing Group Ltd
- Language
- English
- Date published
- 11/01/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984530391802771
Abstract
611 Biodistribution and shedding analysis following treatment with RP1 oncolytic immunotherapy in the skin cancer patients from the IGNYTE clinical trial
Regular and Young Investigator Award Abstracts, Vol.10(Suppl. 2), p.A643
11/01/2022
DOI: 10.1136/jitc-2022-sitc2022.0611
Details
Metrics
15 Record Views